Iambic Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 13.43 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 636.59M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles and drug candidates in the United States and Internationally. It offers products, such as IAM-1363, a selective HER2 inhibitor; IAM-K1, a KIF18A inhibitor; IAM217 (a KIF18A inhibitor) and IAM-C1, a CDK2/4 inhibitor; and services, including drug discovery platform and molecular superintelligence platform which includes technologies, such as Enchant and NeuralPLexer to design and develop small molecule therapeutics. Iambic Therapeutics, Inc. was formerly known as Entos, Inc. and changed its name to Iambic Therapeutics, Inc. in May 2023. The company was incorporated in 2019 and is based in San Diego, California.
Details
| Name | Iambic Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 171 |
| Founded | 2019 |
| Ipo Date | 2026-10-15 |
| Ceo | Thomas Miller |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US45076A1016 |
| Cusip | 45076A101 |
| Cik | 1997038 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Thomas Miller, Ph.D. | Chief Executive Officer and Director |
| Frederick Manby, Ph.D. | Chief Technology Officer and Director |
| Neil Josephson, M.D. | Chief Medical Officer |
| Peter Olson, Ph.D. | Chief Scientific Officer |
| Michael Secora, Ph.D. | Chief Financial Officer and Chief Corporate Development Officer |
| Samit Hirawat, M.D. | Director |
| Evan Rachlin, M.D. | Director |
| William Rastetter, Ph.D. | Director |
| Shalini Sharp | Director |
| Mary Tagliaferri, M.D. | Director |
Contact
| Address | 5627 Oberlin Drive, Suite 120, San Diego, California 92121, United States |
| Phone | (619) 330-5499 |
| Website | https://www.iambic.ai |